Empagliflozin caused slower progression of kidney disease and reduced the rates of renal events compared with placebo when added to standard care.
A program focused on behavior reduced costs and improved glycemic control in children with repeat hospitalizations for diabetic ketoacidosis.
The SGLT2 inhibitor ipragliflozin was effective and well tolerated in Japanese patients with type 2 diabetes on insulin.
Researchers observed significant increases in costs per complication in patients with diabetes who are HDHP members.
Mortality rates have dropped significantly in diabetes patients over the age of 65 but not among those between 55 and 64 years of age.
An automated home monitor may reduce diabetic foot ulcer-related morbidity, mortality, and resource utilization.
T cell mitochondrial dysfunction in patients with type 1 diabetes may lead to abnormal T cell regulation.
The system was feasible, safe, and effective for managing hyperglycemia in this patient population.
Cumulative life stress was a risk factor for developing islet autoimmunity in children with high type 1 diabetes risk.
Faster aspart as part of a basal-bolus regimen improved glycemic control when compared with basal insulin only.
Compared with placebo, liraglutide decreased the rate of cardiovascular events in high-risk patients with diabetes.
Sign Up for Free e-Newsletters
Check out what's trending
Endocrinology Advisor Articles
- Soluble Klotho Levels Predictive of Kidney Failure in Type 2 Diabetes
- Clinicians May Be Overtreating Older Patients With Diabetes
- Comorbid and Pharmacologic Factors Increase Risk for Gastrointestinal Disorders in Diabetes
- Obesity Risk in Infants Born to Women With Diabetes
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Diabetes May Decrease Ability to Feel Acid Regurgitation
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Hormonal Contraceptives May Adversely Affect Psychological Health in Adolescent Girls
- Obesity Can Negatively Effect Liver in Children as Young as 8
- Recommendations Developed on Gender Equity in Medicine